Gerresheimer Pharmaceutical Packaging Mumbai Profile
Key Indicators
- Authorised Capital ₹ 10.75 Cr
as on 24-10-2024
- Paid Up Capital ₹ 2.95 Cr
as on 24-10-2024
- Company Age 14 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 6.48%
(FY 2023)
- Profit 40.05%
(FY 2023)
- Ebitda -25.10%
(FY 2023)
- Net Worth 28.35%
(FY 2023)
- Total Assets 27.48%
(FY 2023)
About Gerresheimer Pharmaceutical Packaging Mumbai
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 10.75 Cr and a paid-up capital of Rs 2.95 Cr, as per Ministry of Corporate Affairs (MCA) records.
Pedakhasim Shaik, Lukas Burkhardt, and Stefan Rieder serve as directors at the Company.
- CIN/LLPIN
U33111MH2010PTC207393
- Company No.
207393
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
01 Sep 2010
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Gerresheimer Pharmaceutical Packaging Mumbai?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pedakhasim Shaik  | Director | 30-Jun-2018 | Current |
Lukas Burkhardt  | Additional Director | 30-Jun-2018 | Current |
Stefan Rieder  | Director | 10-Jul-2020 | Current |
Financial Performance and Corporate Structure Insights of Gerresheimer Pharmaceutical Packaging Mumbai.
Gerresheimer Pharmaceutical Packaging Mumbai Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 6.48% increase. The company also saw a substantial improvement in profitability, with a 40.05% increase in profit. The company's net worth Soared by an impressive increase of 28.35%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Gerresheimer Pharmaceutical Packaging Mumbai?
In 2022, Gerresheimer Pharmaceutical Packaging Mumbai had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Neutral Glass And Alled Industries Pvt.Ltd.Active 38 years 7 monthsPedakhasim Shaik, Lukas Burkhardt and 1 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Gerresheimer Pharmaceutical Packaging Mumbai?
Gerresheimer Pharmaceutical Packaging Mumbai has a workforce of 134 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Gerresheimer Pharmaceutical Packaging Mumbai, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Gerresheimer Pharmaceutical Packaging Mumbai's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
